• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A Mechanism for the Activation of the Influenza Virus Transcriptase

tetano

Editor, Senior Moderator
Mol Cell. 2018 May 25. pii: S1097-2765(18)30361-7. doi: 10.1016/j.molcel.2018.05.011. [Epub ahead of print]
[h=1]A Mechanism for the Activation of the Influenza Virus Transcriptase.[/h] Serna Martin I[SUP]1[/SUP], Hengrung N[SUP]2[/SUP], Renner M[SUP]3[/SUP], Sharps J[SUP]1[/SUP], Mart?nez-Alonso M[SUP]1[/SUP], Masiulis S[SUP]3[/SUP], Grimes JM[SUP]4[/SUP], Fodor E[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza virus RNA polymerase (FluPol), a heterotrimer composed of PB1, PB2, and PA subunits (P3 in influenza C), performs both transcription and replication of the viral RNA genome. For transcription, FluPol interacts with the C-terminal domain (CTD) of RNA polymerase II (Pol II), which enables FluPol to snatch capped RNA primers from nascent host RNAs. Here, we describe the co-crystal structure of influenza C virus polymerase (FluPol[SUB]C[/SUB]) bound to a Ser5-phosphorylated CTD (pS[SUB]5[/SUB]-CTD) peptide. The position of the CTD-binding site at the interface of PB1, P3, and the flexible PB2 C-terminal domains suggests that CTD binding stabilizes the transcription-competent conformation of FluPol. In agreement, both cap snatching and capped primer-dependent transcription initiation by FluPol[SUB]C[/SUB] are enhanced in the presence of pS[SUB]5[/SUB]-CTD. Mutations of amino acids in the CTD-binding site reduce viral mRNA synthesis. We propose a model for the activation of the influenza virus transcriptase through its association with pS[SUB]5[/SUB]-CTD of Pol II.


[h=4]KEYWORDS:[/h] CTD; Pol II; RNA polymerase; cap snatching; influenza virus; replication; transcriptase; transcription

PMID: 29910112 DOI: 10.1016/j.molcel.2018.05.011
Free full text
 
Back
Top Bottom